OncoSec Medical (ONCSQ) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock ONCSQ vs. AMPE, PXMD, CALA, CLVR, EFTR, ATNFW, LBPSW, AEHAW, AIMDW, and ALVOWShould you be buying OncoSec Medical stock or one of its competitors? The main competitors of OncoSec Medical include Ampio Pharmaceuticals (AMPE), PaxMedica (PXMD), Calithera Biosciences (CALA), Clever Leaves (CLVR), eFFECTOR Therapeutics (EFTR), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), and Alvotech (ALVOW). These companies are all part of the "pharmaceutical products" industry. OncoSec Medical vs. Its Competitors Ampio Pharmaceuticals PaxMedica Calithera Biosciences Clever Leaves eFFECTOR Therapeutics 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech OncoSec Medical (NASDAQ:ONCSQ) and Ampio Pharmaceuticals (NYSE:AMPE) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership. Which has stronger earnings & valuation, ONCSQ or AMPE? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOncoSec MedicalN/AN/A-$34.18MN/AN/AAmpio PharmaceuticalsN/AN/A-$8.63M-$11.010.00 Do insiders & institutionals have more ownership in ONCSQ or AMPE? 5.7% of Ampio Pharmaceuticals shares are held by institutional investors. 1.3% of OncoSec Medical shares are held by insiders. Comparatively, 3.3% of Ampio Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media refer more to ONCSQ or AMPE? In the previous week, OncoSec Medical's average media sentiment score of 0.00 equaled Ampio Pharmaceuticals'average media sentiment score. Company Overall Sentiment OncoSec Medical Neutral Ampio Pharmaceuticals Neutral Which has more risk & volatility, ONCSQ or AMPE? OncoSec Medical has a beta of -19.7, suggesting that its stock price is 2,070% less volatile than the S&P 500. Comparatively, Ampio Pharmaceuticals has a beta of 4.69, suggesting that its stock price is 369% more volatile than the S&P 500. Is ONCSQ or AMPE more profitable? Company Net Margins Return on Equity Return on Assets OncoSec MedicalN/A N/A N/A Ampio Pharmaceuticals N/A N/A N/A SummaryAmpio Pharmaceuticals beats OncoSec Medical on 4 of the 4 factors compared between the two stocks. Get OncoSec Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCSQ and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ONCSQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ONCSQ vs. The Competition Export to ExcelMetricOncoSec MedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1K$848.51M$5.78B$9.79BDividend YieldN/A4.84%3.95%4.02%P/E RatioN/A1.1331.2426.59Price / SalesN/A26.55429.49156.00Price / CashN/A19.5637.7359.36Price / BookN/A6.7310.366.68Net Income-$34.18M-$4.20M$3.27B$265.59M OncoSec Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONCSQOncoSec MedicalN/AN/AN/AN/A$1KN/A0.0040AMPEAmpio PharmaceuticalsN/A$0.00flatN/A+22.7%$3KN/A0.0020Gap DownPXMDPaxMedicaN/A$0.00flatN/A-99.9%$2KN/A0.002CALACalithera Biosciences0.5462 of 5 stars$0.00-80.0%N/AN/A$1KN/A0.0060CLVRClever LeavesN/A$0.00+50.0%N/A+0.0%$1K$17.42M0.00560EFTReFFECTOR TherapeuticsN/A$0.00flatN/A-99.6%$1KN/A0.0010High Trading VolumeATNFW180 Life SciencesN/A$0.38-11.6%N/A+2,713.9%$0.00N/A0.007Gap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.00flatN/AN/A$0.00N/A0.002AIMDWAinosN/A$0.48-4.0%N/AN/A$0.00$106.21K0.0040Gap UpALVOWAlvotechN/A$1.25-4.6%N/A-55.5%$0.00$560.10M0.004 Related Companies and Tools Related Companies Ampio Pharmaceuticals Alternatives PaxMedica Alternatives Calithera Biosciences Alternatives Clever Leaves Alternatives eFFECTOR Therapeutics Alternatives 180 Life Sciences Alternatives 4D pharma Alternatives Aesther Healthcare Acquisition Alternatives Ainos Alternatives Alvotech Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ONCSQ) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OncoSec Medical Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share OncoSec Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access